LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Us Congress US
Legislatures
2023-2024 Regular Session
House
Bills
HB2297
US
Us Congress House Bill HB2297
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Meeting Calendar
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB2297
Introduced
3/29/23
Refer
3/29/23
Refer
4/7/23
Caption
To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.
Latest HB2297 Activity
Companion Bills
No companion bills found.
Similar Bills
No similar bills found.